» Articles » PMID: 9336334

Interaction Between Hyperthermia and Oxygen Radical Formation in the 5-hydroxytryptaminergic Response to a Single Methamphetamine Administration

Overview
Specialty Pharmacology
Date 1997 Oct 23
PMID 9336334
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Administration of a single high dose of methamphetamine (METH) causes a rapid and reversible decrease in the activity of the tryptophan hydroxylase (TPH), the rate-limiting enzyme in the synthesis of 5-hydroxytryptamine. This effect can be reversed completely by exposing the METH-impaired enzyme to a reducing environment, which suggests that the decrease in TPH activity is a reversible oxidative consequence of free radical formation. Consistent with this hypothesis, a single METH administration to male rats increased oxygen radical formation, as demonstrated by increased striatal dihydroxybenzoic acid formation after coadministration of salicylate with METH. Prevention of METH-induced hyperthermia attenuated both the increase in dihydroxybenzoic acid formation and the decrease in TPH activity observed 1 h after METH administration. These data suggest that both reactive oxygen species and hyperthermia contribute to the acute decrease in TPH activity which results from a single METH administration.

Citing Articles

N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.

Swanepoel T, Moller M, Harvey B Psychopharmacology (Berl). 2017; 235(1):351-368.

PMID: 29116368 DOI: 10.1007/s00213-017-4776-5.


Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.

Vieira-Brock P, McFadden L, Nielsen S, Ellis J, Walters E, Stout K J Pharmacol Exp Ther. 2015; 355(3):463-72.

PMID: 26391161 PMC: 4658490. DOI: 10.1124/jpet.114.221945.


Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.

Kaushal N, Robson M, Rosen A, McCurdy C, Matsumoto R Eur J Pharmacol. 2014; 724:193-203.

PMID: 24380829 PMC: 3993961. DOI: 10.1016/j.ejphar.2013.12.039.


Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

German C, Fleckenstein A, Hanson G Life Sci. 2013; 97(1):2-8.

PMID: 23911668 PMC: 3909723. DOI: 10.1016/j.lfs.2013.07.023.


The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations.

McFadden L, Hanson G, Fleckenstein A Synapse. 2013; 67(12):875-81.

PMID: 23893609 PMC: 3962656. DOI: 10.1002/syn.21696.